Bioxyne Limited (ASX:BXN) is an Australian life sciences and health products company with a focus on immune health and immunotherapeutic products.

Through our recent acquisition in New Zealand, now trading as Bioxyne International, we are further developing a range of existing functional foods and beauty products containing ingredients sourced exclusively from New Zealand, for our direct sales channel.

Bioxyne has a strategic investment in the consumer dietary supplements and functional foods markets through its proprietary probiotic, Lactobacillus fermentum PCC®. Bioxyne is a company creating value for consumers and investors by delivering safe and effective solutions.

Bioxyne’s focus is currently on the company’s probiotic business and proprietary product Lactobacillus fermentum PCC® which is supported by a manufacturing and distribution agreement with Chr. Hansen (Denmark) a global leader in the manufacturing of natural food additives and supplements products for the food, health, pharmaceutical and agriculture industries.

Bioxyne also has a distribution agreement with Nu-Skin Enterprises (USA) a successful worldwide multilevel marketing company who pride themselves in offering only quality solutions to their customers.